These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12510849)

  • 1. Sopungsungi-won (SP) prevents the onset of hyperglycemia and hyperlipidemia in Zucker diabetic fatty rats.
    Kim YY; Kang HJ; Ko SK; Chung SH
    Arch Pharm Res; 2002 Dec; 25(6):923-31. PubMed ID: 12510849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term administration of Sopungsungi-won (SP) prevents diabetic nephropathy in Zucker diabetic fatty rats.
    Kim YY; Kang KM; Chung SH
    Arch Pharm Res; 2002 Dec; 25(6):917-22. PubMed ID: 12510848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat.
    Smith SA; Lister CA; Toseland CD; Buckingham RE
    Diabetes Obes Metab; 2000 Dec; 2(6):363-72. PubMed ID: 11225966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antecedent hyperglycemia, not hyperlipidemia, is associated with increased islet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats.
    Harmon JS; Gleason CE; Tanaka Y; Poitout V; Robertson RP
    Diabetes; 2001 Nov; 50(11):2481-6. PubMed ID: 11679425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato)oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats.
    Winter CL; Lange JS; Davis MG; Gerwe GS; Downs TR; Peters KG; Kasibhatla B
    Exp Biol Med (Maywood); 2005 Mar; 230(3):207-16. PubMed ID: 15734724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocoa-rich diet ameliorates hepatic insulin resistance by modulating insulin signaling and glucose homeostasis in Zucker diabetic fatty rats.
    Cordero-Herrera I; Martín MÁ; Escrivá F; Álvarez C; Goya L; Ramos S
    J Nutr Biochem; 2015 Jul; 26(7):704-12. PubMed ID: 25814291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
    Wasan KM; Risovic V; Yuen VG; McNeill JH
    J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and zucker diabetic fatty rats and effects of rosiglitazone.
    Cai XJ; Lister CA; Buckingham RE; Pickavance L; Wilding J; Arch JR; Wilson S; Williams G
    Brain Res Mol Brain Res; 2000 Apr; 77(1):131-7. PubMed ID: 10814839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. v- and t-SNARE protein expression in models of insulin resistance: normalization of glycemia by rosiglitazone treatment corrects overexpression of cellubrevin, vesicle-associated membrane protein-2, and syntaxin 4 in skeletal muscle of Zucker diabetic fatty rats.
    Maier VH; Melvin DR; Lister CA; Chapman H; Gould GW; Murphy GJ
    Diabetes; 2000 Apr; 49(4):618-25. PubMed ID: 10871200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adlay Bran Oil Suppresses Hepatic Gluconeogenesis and Attenuates Hyperlipidemia in Type 2 Diabetes Rats.
    Tseng YH; Chang CW; Chiang W; Hsieh SC
    J Med Food; 2019 Jan; 22(1):22-28. PubMed ID: 30673500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo prevention of hyperglycemia also prevents glucotoxic effects on PDX-1 and insulin gene expression.
    Harmon JS; Gleason CE; Tanaka Y; Oseid EA; Hunter-Berger KK; Robertson RP
    Diabetes; 1999 Oct; 48(10):1995-2000. PubMed ID: 10512364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The heme oxygenase system abates hyperglycemia in Zucker diabetic fatty rats by potentiating insulin-sensitizing pathways.
    Ndisang JF; Lane N; Jadhav A
    Endocrinology; 2009 May; 150(5):2098-108. PubMed ID: 19106228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
    Wargent E; Stocker C; Augstein P; Heinke P; Meyer A; Hoffmann T; Subramanian A; Sennitt MV; Demuth HU; Arch JR; Cawthorne MA
    Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: A comparison with PPAR gamma agonism.
    Bergeron R; Yao J; Woods JW; Zycband EI; Liu C; Li Z; Adams A; Berger JP; Zhang BB; Moller DE; Doebber TW
    Endocrinology; 2006 Sep; 147(9):4252-62. PubMed ID: 16728496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats.
    Nawano M; Oku A; Ueta K; Umebayashi I; Ishirahara T; Arakawa K; Saito A; Anai M; Kikuchi M; Asano T
    Am J Physiol Endocrinol Metab; 2000 Mar; 278(3):E535-43. PubMed ID: 10710509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phlorizin treatment prevents the decrease in plasma insulin levels but not the progressive histopathological changes in the pancreatic islets during aging of Zucker diabetic fatty rats.
    Janssen SW; Martens GJ; Sweep CG; Span PN; Verhofstad AA; Hermus AR
    J Endocrinol Invest; 2003 Jun; 26(6):508-15. PubMed ID: 12952363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat.
    Tokuyama Y; Sturis J; DePaoli AM; Takeda J; Stoffel M; Tang J; Sun X; Polonsky KS; Bell GI
    Diabetes; 1995 Dec; 44(12):1447-57. PubMed ID: 7589853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of hyperglycemia in Zucker diabetic fatty rats by exercise training: effects on gene expression in insulin-sensitive tissues determined by high-density oligonucleotide microarray analysis.
    Colombo M; Gregersen S; Kruhoeffer M; Agger A; Xiao J; Jeppesen PB; Orntoft T; Ploug T; Galbo H; Hermansen K
    Metabolism; 2005 Dec; 54(12):1571-81. PubMed ID: 16311088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of fructose 1,6-bisphosphatase reduces excessive endogenous glucose production and attenuates hyperglycemia in Zucker diabetic fatty rats.
    van Poelje PD; Potter SC; Chandramouli VC; Landau BR; Dang Q; Erion MD
    Diabetes; 2006 Jun; 55(6):1747-54. PubMed ID: 16731838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DHEA-PC slows the progression of type 2 diabetes (non-insulin-dependent diabetes mellitus) in the ZDF/Gmi-fa/fa rat.
    Byrne JJ; Bradlow HL
    Diabetes Technol Ther; 2001; 3(2):211-9. PubMed ID: 11478327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.